Chris Lo

All articles by Chris Lo

1. Debate: should countries bring critical drug production home?

   Chris Lo: countries must consider all options for safe API production, including repatriation The pharmaceutical supply chain is an incredibly…
   Read More…

   27 Nov
2. Herd health: agriculture’s role in the global AMR crisis

   In 2019, few would deny that the rising trend of antimicrobial resistance (AMR) represents a global health crisis. Decades of…
   Read More…

   13 Nov
3. Cancer drug discovery: unravelling the mysteries of halichondrin

   In June, the Kishi Lab at Harvard University’s Department of Chemistry and Chemical Biology made an important announcement. A team…
   Read More…

   5 Nov
4. WHO’s Essential Medicines List: discussing innovation and access

   In April this year, the World Health Organization’s (WHO) Expert Committee on the Selection and Use of Essential Medicines met…
   Read More…

   2 Oct
5. Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woes

   Teva Pharmaceutical Industries is a titan of Israel’s pharmaceutical industry. Over the last 30 years the company has evolved into…
   Read More…

   1 Aug
6. Drug development: the researchers driving an open-science approach

   As the era of personalised medicine and medical genetics continues to ramp up, it brings with it ambitions for more…
   Read More…

   11 Apr
7. False flags: are search engines benefiting rogue online pharmacies?

   As consumer spending habits continue to shift from the high street into cyberspace, prompting a retail rush to meet online…
   Read More…

   26 Mar
8. Where is the UK’s supply of Migraleve?

   Since mid-2018, there has been a conspicuous absence on the UK’s pharmacy shelves. Migraleve, an over-the-counter migraine relief medication distributed…
   Read More…

   14 Mar
9. Moderna’s gamble: what’s behind biotech’s biggest-ever IPO?

   In December last year, Cambridge, Massachusetts-based Moderna Therapeutics smashed the record for the biotech industry’s largest initial public offering (IPO)….
   Read More…

   21 Feb
10. antiSMASH: on the hunt for new antibiotics

    With an antimicrobial resistance crisis looming on the public health horizon and a generation of antibiotic treatments falling victim to…
    Read More…

    11 Feb